Literature DB >> 29512216

Copper-Catalyzed Regio- and Enantioselective Aminoboration of Unactivated Terminal Alkenes.

Kodai Kato1, Koji Hirano1, Masahiro Miura1.   

Abstract

A CuCl/(R,R)-PTBP-BDPP-catalyzed regioselective and enantioselective aminoboration of simple and unactivated terminal alkenes with bis(pinacolato)diboron (pinB-Bpin) and hydroxylamines has been developed. The amino group and boryl group were incorporated at the internal position and terminal position, respectively, and the corresponding chiral β-borylalkylamines were obtained with good to high enantiomeric ratios. The asymmetric copper catalysis allows rapid and concise transformation of readily available olefinic feedstock-like materials into functionalized chiral alkylamines of high potential in medicinal and pharmaceutical chemistry.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  asymmetric catalysis; boron; chiral amine; copper; electrophilic amination

Year:  2018        PMID: 29512216     DOI: 10.1002/chem.201801070

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Cu-Catalyzed Asymmetric Aminoboration of E-Vinylarenes with pivZPhos as the Ligand.

Authors:  Linglin Wu; Olga Zatolochnaya; Bo Qu; Ling Wu; Lucille A Wells; Marisa C Kozlowski; Chris H Senanayake; Jinhua J Song; Yongda Zhang
Journal:  Org Lett       Date:  2019-10-24       Impact factor: 6.005

2.  A Diastereodivergent and Enantioselective Approach to syn- and anti-Diamines: Development of 2-Azatrienes for Cu-Catalyzed Reductive Couplings with Imines That Furnish Allylic Amines.

Authors:  Pengfei Zhou; Xinxin Shao; Steven J Malcolmson
Journal:  J Am Chem Soc       Date:  2021-08-23       Impact factor: 16.383

Review 3.  Beyond Carbon: Enantioselective and Enantiospecific Reactions with Catalytically Generated Boryl- and Silylcopper Intermediates.

Authors:  Weichao Xue; Martin Oestreich
Journal:  ACS Cent Sci       Date:  2020-07-09       Impact factor: 14.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.